THESEUS PHARMACEUTICALS, INC. Patent Applications Rejected
3 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-09-25: Application 18552302; Invention MACROCYCLIC EGFR INHIBITORS FOR THE TREATMENT OF CANCER; Applicant Theseus Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2023-06-29: Application 18259903; Invention AMINOTHIAZOLE COMPOUNDS AS C-KIT INHIBITORS; Applicant Theseus Pharmaceuticals, Inc.; Status Abandoned -- Incomplete Application (Pre-examination).
- 2023-01-03: Application 17800330; Invention MACROCYCLIC COMPOUNDS AND USES THEREOF; Applicant THESEUS PHARMACEUTICALS, INC.; Status Abandoned -- Failure to Pay Issue Fee.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2023-09-25 | 18552302 | MACROCYCLIC EGFR INHIBITORS FOR THE TREATMENT OF CANCER | Theseus Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20240199614A1 | Wei-Sheng HUANG William C. SHAKESPEARE Charles J. EYERMANN David C. DALGARNO | United States United States United States United States | |
| 2023-06-29 | 18259903 | AMINOTHIAZOLE COMPOUNDS AS C-KIT INHIBITORS | Theseus Pharmaceuticals, Inc. | Abandoned -- Incomplete Application (Pre-examination) | US20240317731A1 | David C. DALGARNO Wei-Sheng HUANG William C. SHAKESPEARE | United States United States United States | |
| 2023-01-03 | 17800330 | MACROCYCLIC COMPOUNDS AND USES THEREOF | THESEUS PHARMACEUTICALS, INC. | Abandoned -- Failure to Pay Issue Fee | US20230148005A1 | Wei-Sheng Huang William C. SHAKESPEARE Charles J. EYERMANN David C. DALGARNO | United States United States United States United States | VALLE, ERNESTO |